142 related articles for article (PubMed ID: 27341035)
1. Hepatitis B virus antigens impair NK cell function.
Yang Y; Han Q; Zhang C; Xiao M; Zhang J
Int Immunopharmacol; 2016 Sep; 38():291-7. PubMed ID: 27341035
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.
Jegaskanda S; Ahn SH; Skinner N; Thompson AJ; Ngyuen T; Holmes J; De Rose R; Navis M; Winnall WR; Kramski M; Bernardi G; Bayliss J; Colledge D; Sozzi V; Visvanathan K; Locarnini SA; Kent SJ; Revill PA
J Virol; 2014 Sep; 88(18):10412-20. PubMed ID: 24872585
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic natural killer cell activation, but not function, is associated with HBsAg levels in patients with HBeAg-negative chronic hepatitis B.
Tjwa ET; Zoutendijk R; van Oord GW; Biesta PJ; Verheij J; Janssen HL; Woltman AM; Boonstra A
Liver Int; 2014 Mar; 34(3):396-404. PubMed ID: 23890390
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO.
Wang Y; Cui L; Yang G; Zhan J; Guo L; Chen Y; Fan C; Liu D; Guo D
J Virol; 2019 Jan; 93(2):. PubMed ID: 30404796
[TBL] [Abstract][Full Text] [Related]
5. HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication.
Wang XX; Pan XB; Han JC; Cong X; Jin Q; Kong XS; Wei L; Feng B
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):233-240. PubMed ID: 29625837
[TBL] [Abstract][Full Text] [Related]
6. Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir.
Stelma F; de Niet A; Tempelmans Plat-Sinnige MJ; Jansen L; Takkenberg RB; Reesink HW; Kootstra NA; van Leeuwen EM
J Infect Dis; 2015 Oct; 212(7):1042-51. PubMed ID: 25791117
[TBL] [Abstract][Full Text] [Related]
7. STAT1 is associated with NK cell dysfunction by downregulating NKG2D transcription in chronic HBV-infected patients.
Huang X; Mo Q; Fu T; Liu Y; Diao B
Immunobiology; 2022 Nov; 227(6):152272. PubMed ID: 36122437
[TBL] [Abstract][Full Text] [Related]
8. HBsAg Dampened STING Associated Activation of NK Cells in HBeAg-Negative CHB Patients.
Zheng B; Yu Y; Pan Z; Feng Y; Zhao H; Han Q; Zhang J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299262
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes/macrophages by interfering with JNK activation.
Wang S; Chen Z; Hu C; Qian F; Cheng Y; Wu M; Shi B; Chen J; Hu Y; Yuan Z
J Immunol; 2013 May; 190(10):5142-51. PubMed ID: 23585678
[TBL] [Abstract][Full Text] [Related]
10. p38 mitogen-activated protein kinase impairment of innate immune cells is a characteristic feature of HBeAg-negative chronic hepatitis B.
Bakarozi M; Mavropoulos A; Bogdanos DP; Dalekos GN; Rigopoulou EI
J Viral Hepat; 2020 Jan; 27(1):52-60. PubMed ID: 31520461
[TBL] [Abstract][Full Text] [Related]
11. Human hepatitis B virus surface and e antigens inhibit major vault protein signaling in interferon induction pathways.
Liu S; Peng N; Xie J; Hao Q; Zhang M; Zhang Y; Xia Z; Xu G; Zhao F; Wang Q; Han T; Zhu Y
J Hepatol; 2015 May; 62(5):1015-23. PubMed ID: 25481566
[TBL] [Abstract][Full Text] [Related]
12. Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation.
Li W; Jiang Y; Wang X; Jin J; Qi Y; Chi X; Zhang H; Feng X; Niu J
PLoS One; 2015; 10(8):e0135874. PubMed ID: 26291078
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B.
Boni C; Lampertico P; Talamona L; Giuberti T; Invernizzi F; Barili V; Fisicaro P; Rossi M; Cavallo MC; Vecchi A; Pedrazzi G; Alfieri A; Colombo M; Missale G; Ferrari C
Hepatology; 2015 Dec; 62(6):1697-709. PubMed ID: 26361374
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus surface antigen can activate human monocyte-derived dendritic cells by nuclear factor kappa B and p38 mitogen-activated protein kinase mediated signaling.
Jan RH; Lin YL; Chen CJ; Lin TY; Hsu YC; Chen LK; Chiang BL
Microbiol Immunol; 2012 Oct; 56(10):719-27. PubMed ID: 22853328
[TBL] [Abstract][Full Text] [Related]
16. Downregulation and altered function of natural killer cells in hepatitis B virus patients treated with entecavir.
Zhao PW; Jia FY; Shan YX; Ji HF; Feng JY; Niu JQ; Ayana DA; Jiang YF
Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):190-6. PubMed ID: 23278368
[TBL] [Abstract][Full Text] [Related]
17. A large-scale analysis study on the clinical and viral characteristics of hepatitis B infection with concurrence of hepatitis B surface or E antigens and their corresponding antibodies.
Xiang Y; Chen P; Xia JR; Zhang LP
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252163
[TBL] [Abstract][Full Text] [Related]
18. Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction.
Yang Y; Han Q; Hou Z; Zhang C; Tian Z; Zhang J
Cell Mol Immunol; 2017 May; 14(5):465-475. PubMed ID: 27238466
[TBL] [Abstract][Full Text] [Related]
19. The impact of hepatitis B surface antigen on natural killer cells in patients with chronic hepatitis B virus infection.
Du Y; Anastasiou OE; Strunz B; Scheuten J; Bremer B; Kraft A; Kleinsimglinhaus K; Todt D; Broering R; Hardtke-Wolenski M; Wu J; Yang D; Dittmer U; Lu M; Cornberg M; Björkström NK; Khera T; Wedemeyer H
Liver Int; 2021 Sep; 41(9):2046-2058. PubMed ID: 33794040
[TBL] [Abstract][Full Text] [Related]
20. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.
Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A
J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
